mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.2 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.2 |